These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8252577)

  • 1. Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation.
    Weissberg PL; Grainger DJ; Shanahan CM; Metcalfe JC
    Cardiovasc Res; 1993 Jul; 27(7):1191-8. PubMed ID: 8252577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells.
    Grainger DJ; Hesketh TR; Weissberg PL; Metcalfe JC
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):403-8. PubMed ID: 1575685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
    Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
    Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum.
    Underwood PA; Mitchell SM; Whitelock JM
    J Vasc Res; 1998; 35(6):449-60. PubMed ID: 9858870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of vascular smooth muscle cell proliferation.
    Weissberg PL
    Ann Acad Med Singap; 1991 Jan; 20(1):38-42. PubMed ID: 2029162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein synthesis and antiproliferative effect of the angiotensin converting enzyme inhibitor trandolaprilat in rat vascular smooth muscle cells.
    Uehara Y; Numabe A; Kawabata Y; Takada S; Hirawa N; Nagata T; Ikeda T; Yagi S; Omata M
    J Hypertens; 1993 Oct; 11(10):1073-81. PubMed ID: 8258671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats.
    Wolf SC; Sauter G; Risler T; Brehm BR
    Ren Fail; 2005; 27(4):465-74. PubMed ID: 16060137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats.
    Sato M; Ohsaki Y; Tobise K
    Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta.
    Kirschenlohr HL; Metcalfe JC; Weissberg PL; Grainger DJ
    Cardiovasc Res; 1995 Jun; 29(6):848-55. PubMed ID: 7656289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin.
    Resink TJ; Scott-Burden T; Baur U; Bürgin M; Bühler FR
    J Cell Physiol; 1989 Jan; 138(1):137-44. PubMed ID: 2910881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.
    Delmolino LM; Castellot JJ
    J Cell Physiol; 1997 Dec; 173(3):371-9. PubMed ID: 9369950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth characteristics of pulmonary artery smooth muscle cells from fawn-hooded rats.
    Janakidevi K; Tiruppathi C; Del Vecchio PJ; Pinheiro JM; Malik AB
    Am J Physiol; 1995 Mar; 268(3 Pt 1):L465-70. PubMed ID: 7900828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype.
    Hu WY; Fukuda N; Ikeda Y; Suzuki R; Tahira Y; Takagi H; Matsumoto K; Kanmatsuse K; Mugishima H
    J Cell Physiol; 2003 Aug; 196(2):284-92. PubMed ID: 12811821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation.
    Takagi Y
    Hokkaido Igaku Zasshi; 2002 May; 77(3):221-30. PubMed ID: 12056049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L; Huangpu J; Karnovsky MJ
    Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental regulation of transforming growth factor-beta 1 responses and vascular smooth muscle growth in spontaneously hypertensive rats.
    Saltis J; Bobik A
    J Hypertens; 1995 Dec; 13(12 Pt 1):1441-8. PubMed ID: 8866906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Galphaq in smooth muscle cell proliferation.
    Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
    J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells.
    Yamamoto H; Tsuruoka S; Ioka T; Ando H; Ito C; Akimoto T; Fujimura A; Asano Y; Kusano E
    Kidney Int; 2006 May; 69(10):1780-5. PubMed ID: 16612331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration.
    Papakonstantinou E; Karakiulakis G; Eickelberg O; Perruchoud AP; Block LH; Roth M
    Glycobiology; 1998 Aug; 8(8):821-30. PubMed ID: 9639543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.